text_1: Genomic aberrations of metastases provide information for targeted therapy.
text_2: We also demonstrate the importance of germline polymorphisms in determining allele-specific mutations, and we identify somatic genetic alterations that are specifically related to initiation of carcinogenesis by Hras or Kras mutations.